Novel Radioenhancer NBTXR3 Activated by Radiotherapy in Cisplatin-Ineligible Locally Advanced HNSCC Patients: Final and Exploratory Results of a Phase I Trial

• DOI: 10.1016/j.ijrobp.2024.01.022
• Publication Date: 2024-03-14T07:08:15Z
• Authors: C. Le Tourneau; X. Liem; T.V.F. Nguyen; S. El Bedoui; S. Salas; M. Plana Serrahima; X. Mirabel; S. Wong Hee Kam; L. Houdas; A. Debard; O.I. Vivar; L.A. Farber; J.O. Thariat; M. Lesnik; F. Helferich; A. Herczeg; Z. Papai; J. Fijuth; Z. Takacsi-Nagy